Media coverage
1
Media coverage
Title A Randomized Controlled Trial of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks Compared to Sofosbuvir with Ribavirin for 12 Weeks in Genotype 2 HCV-Infected Patients: The Phase 3 ASTRAL-2 Study Media name/outlet National AIDS Treatment Advocacy Project Country United States Date 12/1/15 Persons Jing Wang, Eric J Lawitz